[Yersinia pestis as a dangerous biological weapon] - PubMed (original) (raw)
[Article in Polish]
Affiliations
- PMID: 12474416
Review
[Yersinia pestis as a dangerous biological weapon]
[Article in Polish]
Sambor Grygorczuk et al. Med Pr. 2002.
Abstract
Plague is an infectious disease caused by the Yersinia pestis microorganism, which is transmitted to the human host from a natural reservoir (different rodent species) by a flea bite. Plague is still encountered in humans in the areas of its enzootic prevalence in local rodent populations. Infection by flea bite results in a bubonic or septicemic plague, possibly complicated by secondary pneumonia. The person with pneumonic symptoms may be a source of a droplet-borne inhalatory infection for other people who consequently develop primary pneumonic plague. Despite a clinical form, plague is a severe infection characterized by a short incubation period, rapid onset and quick progress with mortality exceeding 50% if not treated properly. The pneumonic plague is associated with a particularly rapid progress and the mortality rate of almost 100% if not treated properly. As Yersinia pestis can be easily obtained and cultured and is highly pathogenic for humans, it poses a serious threat of being used for bioterrorism purposes. Artificially created aerosol containing plague bacilli can cause numerous and almost simultaneous cases of primary pulmonic plague in an exposed population. Persons exposed would most likely develop severe pneumonia with rapidly progressing respiratory and circulatory failure. The use of the Yersinia pestis strains resistant to antibiotics typically applied cannot be excluded.
Similar articles
- Yersinia pestis: still a plague in the 21st century.
Josko D. Josko D. Clin Lab Sci. 2004 Winter;17(1):25-9. Clin Lab Sci. 2004. PMID: 15011977 Review. - [Pulmonic plague].
Hovette P, Burgel PR, Camara P, Sane M, Auregan G, Klotz F. Hovette P, et al. Rev Pneumol Clin. 1998 Dec;54(6):373-6. Rev Pneumol Clin. 1998. PMID: 10100351 French. - [Yersinia pestis and plague - an update].
Stock I. Stock I. Med Monatsschr Pharm. 2014 Dec;37(12):441-8; quiz 449. Med Monatsschr Pharm. 2014. PMID: 25643450 Review. German. - Progress on plague vaccine development.
Rosenzweig JA, Jejelowo O, Sha J, Erova TE, Brackman SM, Kirtley ML, van Lier CJ, Chopra AK. Rosenzweig JA, et al. Appl Microbiol Biotechnol. 2011 Jul;91(2):265-86. doi: 10.1007/s00253-011-3380-6. Epub 2011 Jun 14. Appl Microbiol Biotechnol. 2011. PMID: 21670978 - Plague.
Cobbs CG, Chansolme DH. Cobbs CG, et al. Dermatol Clin. 2004 Jul;22(3):303-12, vi. doi: 10.1016/j.det.2004.03.007. Dermatol Clin. 2004. PMID: 15207311 Review.
Cited by
- Insight into microevolution of Yersinia pestis by clustered regularly interspaced short palindromic repeats.
Cui Y, Li Y, Gorgé O, Platonov ME, Yan Y, Guo Z, Pourcel C, Dentovskaya SV, Balakhonov SV, Wang X, Song Y, Anisimov AP, Vergnaud G, Yang R. Cui Y, et al. PLoS One. 2008 Jul 9;3(7):e2652. doi: 10.1371/journal.pone.0002652. PLoS One. 2008. PMID: 18612419 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical
Research Materials